Nothing Special   »   [go: up one dir, main page]

AU1873097A - Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions - Google Patents

Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions

Info

Publication number
AU1873097A
AU1873097A AU18730/97A AU1873097A AU1873097A AU 1873097 A AU1873097 A AU 1873097A AU 18730/97 A AU18730/97 A AU 18730/97A AU 1873097 A AU1873097 A AU 1873097A AU 1873097 A AU1873097 A AU 1873097A
Authority
AU
Australia
Prior art keywords
transplantation
gene therapy
inflammatory conditions
apoptotic proteins
entothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18730/97A
Inventor
Fritz H. Bach
Christiane Ferran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Beth Israel Deaconess Medical Center Inc
Original Assignee
Ciba Geigy AG
Novartis AG
New England Deaconess Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG, New England Deaconess Hospital filed Critical Ciba Geigy AG
Publication of AU1873097A publication Critical patent/AU1873097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU18730/97A 1996-02-14 1997-02-13 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions Abandoned AU1873097A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60151596A 1996-02-14 1996-02-14
US601515 1996-02-14
US63499596A 1996-04-19 1996-04-19
US634995 1996-04-19
PCT/EP1997/000676 WO1997030083A1 (en) 1996-02-14 1997-02-13 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions

Publications (1)

Publication Number Publication Date
AU1873097A true AU1873097A (en) 1997-09-02

Family

ID=27083879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18730/97A Abandoned AU1873097A (en) 1996-02-14 1997-02-13 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions

Country Status (5)

Country Link
EP (1) EP0886650A1 (en)
JP (1) JP2000510326A (en)
AU (1) AU1873097A (en)
CA (1) CA2245503A1 (en)
WO (1) WO1997030083A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8075880B2 (en) 1999-01-11 2011-12-13 Steward St. Elizabeth's Medical Center Of Boston, Inc. Compositions and methods for regulating angiogenesis
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
JPH1175859A (en) * 1997-09-08 1999-03-23 R P R Jienseru Kk Apoptosis-related gene expressible virus vector system
US6436393B1 (en) * 1998-04-29 2002-08-20 Guadalupe Bilbao Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof
US20020071824A1 (en) * 1999-05-27 2002-06-13 Nick Giannoukakis Gene transfer to pancreatic b cells for prevention of islet dysfunction
AU2001231009A1 (en) 2000-01-21 2001-07-31 Beth Israel Deaconess Medical Center Use of pro-apoptotic factors in treatment of atherosclerosis
AU4419801A (en) * 2000-03-08 2001-09-17 Akzo Nobel N.V. Synergistic activation of regulatory elements by rel proteins and a steroid receptor
KR100426455B1 (en) * 2000-04-25 2004-04-13 김진우 Human cancer suppressor gene, protein encoding by same, expression vector containing same, and cell transformed by said vector
AU2001274905B2 (en) 2000-05-22 2006-12-07 Johns Hopkins University Genetic engineering of vascular grafts to resist disease
KR100434591B1 (en) * 2002-04-16 2004-06-04 김진우 Human cancer suppressor gene, protein encoded therein, expression vector containing same, and cell transformed by said vector
US7470538B2 (en) 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
EP2527837A1 (en) * 2004-10-04 2012-11-28 University of Washington Methods of inhibiting cell death or inflammation in a mammal
WO2008060776A2 (en) * 2006-10-03 2008-05-22 University Of Medicine And Dentistry Of New Jersey Atap peptides, nucleic acids encoding the same and associated methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0568537B1 (en) * 1990-10-31 1998-02-04 Somatix Therapy Corporation Genetic modification of endothelial cells
EP0584238A1 (en) * 1991-05-17 1994-03-02 Chiron Corporation INHIBITOR OF NF-$g(k)B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF
US5556763A (en) * 1992-04-06 1996-09-17 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Evaluation and treatment of patients with progressive immunosuppression
WO1993020219A1 (en) * 1992-04-06 1993-10-14 The Government Of The United States As Represented By The Secretary, Department Of Health And Human Services Control and/or prevention of binding of nf-kb/rel/dorsal (nrd) family proteins to dna
GB9222931D0 (en) * 1992-11-02 1992-12-16 Sandoz Ltd Organic compounds
US5646008A (en) * 1993-06-22 1997-07-08 The Regent Of The University Of Michigan Vertebrate apoptosis gene: compositions and methods

Also Published As

Publication number Publication date
EP0886650A1 (en) 1998-12-30
WO1997030083A1 (en) 1997-08-21
CA2245503A1 (en) 1997-08-21
JP2000510326A (en) 2000-08-15

Similar Documents

Publication Publication Date Title
AU9397098A (en) Methods and cell line useful for production of recombinant adeno-associated viruses
AU1644295A (en) Cell culture substrates and methods of use
AU4330597A (en) Serum-free mammalian cell culture medium, and uses thereof
AU9582398A (en) Methods and devices for the long-term culture of hematopoietic progenitor cells
AU2730497A (en) Cryopreservation and extensive subculturing of human mesenchymal stem cells
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU1498497A (en) Isolation and sequencing of the hazel FAD2-N gene
AU3462899A (en) Sequence and method for genetic engineering of proteins with cell membrane translocating activity
AU2569599A (en) Cells or tissues with increased protein factors and methods of making and using same
AU1873097A (en) Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
AU2386997A (en) Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
AU2387795A (en) Culture medium for maintaining viability of mammalian cells
HK1038382A1 (en) Delivery of proteins into eukaryotic cells with recombinant yersinia
AU5380898A (en) In culture proliferation of human pancreatic endocrine cells
AU5147996A (en) Gene therapy for transplantation and inflammatory or thrombo tic conditions
AU6043396A (en) Composition and methods for creating syngeneic recombinant v irus-producing cells
AU4378996A (en) Cell compositions for use in transplantation and ex vivo gene therapy
AU2197897A (en) Use of delta-like protein to inhibit the differentiation of stem cells
AU3823795A (en) Novel mammalian protein associated with uncontrolled cell division
AU4064897A (en) Mammalian ribonuclease inhibitors and use thereof
AU3518695A (en) Gene therapy for transplantation and inflammatory or thrmbotic conditions
AU3813597A (en) Serum-free medium for growth of anchorage-dependant mammalian cells
AU3288497A (en) Mammalian tolloid-like gene and protein
AU1685895A (en) Hematopoietic cell expansion and transplantation methods
AU8827998A (en) Porcine totipotent cells and method for long-term culture